Resumo

ACOSTA, Natalia et al. Prognostic biomarkers in patients with localised prostate cancer. rev.colomb.cancerol. [online]. 2017, vol.21, n.2, pp.113-125. ISSN 0123-9015.  https://doi.org/10.1016/j.rccan.2016.07.004.

Treatment for localised prostate cancer (radical prostatectomy or radiotherapy), offers high cure rates; nevertheless, 20% to 30% of the cases develop biochemical recurrence. There are clinical and pathological features that are currently being used to predict recurrence of the disease. However, tumour heterogeneity in prostate cancer, along with differences in time of progression to metastasis and treatment resistance, have led to inaccuracies in predicting the risk of biochemical relapse, and therefore, misleading in treatment decisions. Because of this, many genetic markers have been studied in order to refine risk stratification and improve treatment decisions in a suitable and opportune manner. This paper presents a review of molecular prognostic markers that have been proposed in patients with localised prostate cancer, which potentially could allow establishing the risk of recurrence of the disease more accurately.

Palavras-chave : Prostatic neoplasms; Biological markers; Prognosis.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )